E.E. Geduld’s Teva Pharmaceuticals TEVA Stock Holding History

E.E. Geduld’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,000	Closed	-$262K	–	274
2014 Q2	$262K	Sell	5,000 -10,000	-67%	-$511K	0.16%	150
2014 Q1	$793K	Buy	+15,000	New	+$693K	0.43%	49

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

E.E. Geduld's TEVA Position: Q3 2014 in Review

E.E. Geduld sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 5,000 shares — an estimated $262K sold.

E.E. Geduld first reported a position in TEVA in Q1 2014 and held it in 2 quarters. The position peaked at $793K in Q1 2014. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

E.E. Geduld reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
E.E. Geduld sold 5,000 Teva Pharmaceuticals shares in Q3 2014, an estimated $262K.
E.E. Geduld first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 2 quarters.
E.E. Geduld's Teva Pharmaceuticals position peaked at $793K in Q1 2014.
772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on E.E. Geduld's 13F filing for Q3 2014, filed 30 Oct 2014.